Session Description: 

Neuro-oncology tumor board conferences allow neurosurgeons, medical and radiation oncologists, and other oncology professionals to present patient cases in order to educate attendees on new surgical procedures or treatments and receive a consensus of recommendations for treatment. New procedures or journal articles are discussed as well as clinical trial patients may be eligible to enroll in.

Target Audience: 

Physicians (MD or DO)

Other Healthcare Professionals

Learning Objectives- After Attending this Activity, Learners Should be Able to:

1. Discuss the process for time-sensitive enrollment into open clinical trials for newly diagnosed, or recurrent, brain cancer patients.

2. Review, analyze, and discuss current peer reviewed journal articles on topics relevant to neuro-oncology with the goal of improving quality of care for patients.

3. Demonstrate cultural humility in interactions with families of diverse cultures and belief systems that influence how they perceive health and illness and respond to neuro-oncology diseases, symptoms and treatments.

4. Utilize evidence-based medicine to identify care and treatment options for optimal treatment of complex and unusual neuro-oncology disease presentations.

Providing Culturally Appropriate Care which is Free of Implicit Biases (AB 1195 & 241):

• Fiscella, K., Epstein, R., Griggs, J., Marshall, M., & Shields, C. (2021). Is physician implicit bias associated with differences in care by patient race for metastatic cancer-related pain? PLOS ONE 16(10). https://doi.org/10.1371/journal.pone.0257794
• Chaiyachati, K., Krause, D., Sugalski, J., Graboyes, E., & Shulman, L. (2023). A survey of the National Comprehensive Cancer Network on approaches toward addressing patients’ transportation insecurity. J Natl Compr Canc Netw;21(1):21-26. doi: 10.6004/jnccn.2022.7073. https://pubmed.ncbi.nlm.nih.gov/36634609/
• Bush, B., Raney, P., Maingi, S., & Pratt, M. (2023). Best practices for addressing the health needs of the LGBTQ+ community in oncology care. JNCCN;21(5.5). https://doi.org/10.6004/jnccn.2023.5008

Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest

Lawrence Dickinson, faculty for this presentation, receives speaker fees from NICO and consultant fees from Integra. These relevant ineligible relationships were mitigated via a faculty attestation that all clinical recommendations are evidence-based and free of commercial bias (e.g., peer-reviewed literature, adhering to evidence-based practice guidelines).

No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.   

– Provider Designee/Verification:  Kerri Maya, PhD(c), MSL, RN, NPD-BC